The SITELINE 2 Polyurethane Clinical Investigation analyzed the safety and electrical performance of the SITELINE 2 Polyurethane pacing lead.
This was a prospective, single-arm, multi-center U.S. clinical investigation, designed to demonstrate the safety and effectiveness of the SITELINE 2 Polyurethane extendable, retractable pacing lead in humans
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
200
SITELINE 2 Polyurethane (pacing lead)
Multiple Locations in the United States
Saint Paul, Minnesota, United States
Pacing voltage threshold at 3 Months
Time frame: 3 months
Pacing impedance at 3 Months
Time frame: 3 months
Sensed amplitude at 3 Months
Time frame: 3 months
Lead complication-free rate up to 3 Months
Time frame: 3 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.